Literature DB >> 4790941

Isolation of regulatory mutants of the aspartic and pyruvic acid families and their effect on antibiotic production in Streptomyces lipmanii.

O W Godfrey.   

Abstract

Streptomyces lipmanii L100 produces two beta-lactam ring-containing antibiotics: penicillin N and 7-(5-amino-5-carboxy valeramido)-7-methoxy-cephalosporanic acid. These antibiotics are modified tripeptides derived from alpha-aminoadipic acid, cysteine, and valine. Mutants defective either in the biosynthesis or in the control of amino acids belonging to the aspartic and pyruvic acid families were isolated and characterized with regard to their effect on antibiotic synthesis. In a number of these mutants antibiotic synthesis was either completely inhibited or increased up to threefold over wild-type levels.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4790941      PMCID: PMC444509          DOI: 10.1128/AAC.4.2.73

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  The structure of cephalesporin C.

Authors:  E P ABRAHAM; G G NEWTON
Journal:  Biochem J       Date:  1961-05       Impact factor: 3.857

2.  The isolation and characterization of auzotrophs of the aspartic acid family from Streptomyces lipmanii.

Authors:  J R Kirkpatrick; O W Godfrey
Journal:  Folia Microbiol (Praha)       Date:  1973       Impact factor: 2.099

3.  End-product control of acetohydroxyacid synthetase by valine in Penicillium chrysogenum Q 176 and a high penicillin-yielding mutant.

Authors:  S A Goulden; F W Chattaway
Journal:  J Gen Microbiol       Date:  1969-11

4.  Enzymatic synthesis of L-cystathionine from the succinic ester of L-homoserine.

Authors:  M M Kaplan; M Flavin
Journal:  Biochim Biophys Acta       Date:  1965-07-08

5.  Beta-lactam antibiotics from Streptomyces.

Authors:  R Nagarajan; L D Boeck; M Gorman; R L Hamill; C E Higgens; M M Hoehn; W M Stark; J G Whitney
Journal:  J Am Chem Soc       Date:  1971-05-05       Impact factor: 15.419

6.  Metabolism of basic amino acids in Pseudomonas putida. Catabolism of lysine by cyclic and acyclic intermediates.

Authors:  D L Miller; V W Rodwell
Journal:  J Biol Chem       Date:  1971-05-10       Impact factor: 5.157

7.  Biosynthesis of pyrrolnitrins by analogue-resistant mutants of Pseudomonas fluorescens.

Authors:  R P Elander; J A Mabe; R L Hamill; M Gorman
Journal:  Folia Microbiol (Praha)       Date:  1971       Impact factor: 2.099

8.  Role of methionine in cephalosporin synthesis.

Authors:  P G Caltrider; H F Niss
Journal:  Appl Microbiol       Date:  1966-09

9.  Mutant strains of Escherichia coli K12 that use D-amino acids.

Authors:  J Kuhn; R L Somerville
Journal:  Proc Natl Acad Sci U S A       Date:  1971-10       Impact factor: 11.205

10.  Incorporation of labeled precursors into A16886B, a novel -lactam antibiotic produced by Streptomyces clavuligerus.

Authors:  J G Whitney; D R Brannon; J A Mabe; K J Wicker
Journal:  Antimicrob Agents Chemother       Date:  1972-03       Impact factor: 5.191

View more
  5 in total

1.  Methods for mutation and selection of the ergot fungus.

Authors:  S Srikrai; J E Robbers
Journal:  Appl Environ Microbiol       Date:  1983-04       Impact factor: 4.792

Review 2.  Control of antibiotic biosynthesis.

Authors:  J F Martin; A L Demain
Journal:  Microbiol Rev       Date:  1980-06

3.  Method for selection of transposable DNA and characterization of a new insertion sequence, IS493, from Streptomyces lividans.

Authors:  P J Solenberg; S G Burgett
Journal:  J Bacteriol       Date:  1989-09       Impact factor: 3.490

4.  Streptomyces lipmanii expresses two restriction systems that inhibit plasmid transformation and bacteriophage plaque formation.

Authors:  P Matsushima; R H Baltz
Journal:  J Bacteriol       Date:  1989-06       Impact factor: 3.490

5.  Regulatory mutants of Streptomyces clavuligerus affected in free diaminopimelic acid content and antibiotic biosynthesis.

Authors:  Y Aharonowitz; S Mendelovitz; F Kirenberg; V Kuper
Journal:  J Bacteriol       Date:  1984-01       Impact factor: 3.490

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.